Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1432]

Personalised tumour vaccines improve interleukin-2 treated metastatic melanoma

Personalised tumour vaccines improve interleukin-2 treated metastatic melanoma

ASCO GI: New, rationally-based chemotherapy combination appears highly effective in patients with treatment-resistant neuroendocrine tumours

ASCO GI: New, rationally-based chemotherapy combination appears highly effective in patients with treatment...

FDA approval for combination of trametinib with dabrafenib for treatment of melanoma

FDA approval for combination of trametinib with dabrafenib for treatment of melanoma

Immune profile of lymph nodes nearest to tumour may predict melanoma progression

Semantic Web Applications and Tools for Life Sciences (SWAT4LS Workshop in Edinburgh 2013)

Semantic Web Applications and Tools for Life Sciences (SWAT4LS Workshop in Edinburgh 2013)

UK cancer death rates drop by 20 per cent over 20 years

UK cancer death rates drop by 20 per cent over 20 years

Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancers must be addressed

Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancers must be addressed

£100m investment in research centres across the UK

£100m investment in research centres across the UK

Insight into melanoma drug resistance pathways identifies potential new treatment option

Insight into melanoma drug resistance pathways identifies potential new treatment option

Studies identify cell-signaling pathway alterations responsible for melanoma drug resistance

Studies identify cell-signaling pathway alterations responsible for melanoma drug resistance

More from ecancer